2005
DOI: 10.1378/chest.127.3.731
|View full text |Cite
|
Sign up to set email alerts
|

Low Plasma Orexin-A Levels Were Improved by Continuous Positive Airway Pressure Treatment in Patients With Severe Obstructive Sleep Apnea-Hypopnea Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
36
0
3

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(43 citation statements)
references
References 40 publications
4
36
0
3
Order By: Relevance
“…Given that hypocretin play a role in respiratory and cardiac control as well as interaction between sleep and cardiovascular system, authors supposed that may be the result not only of the hypocretinergic deficiency per se but also of the altered sleep/wake regulation. Because it was reported that OSAHS patients had lower levels of plasma orexin-A 41 and could be improved by CPAP treatment 42, we suppose this might also contribute to the association between EDS and hypertension in our study of OSAHS.…”
Section: Discussionmentioning
confidence: 83%
“…Given that hypocretin play a role in respiratory and cardiac control as well as interaction between sleep and cardiovascular system, authors supposed that may be the result not only of the hypocretinergic deficiency per se but also of the altered sleep/wake regulation. Because it was reported that OSAHS patients had lower levels of plasma orexin-A 41 and could be improved by CPAP treatment 42, we suppose this might also contribute to the association between EDS and hypertension in our study of OSAHS.…”
Section: Discussionmentioning
confidence: 83%
“…Findings on the effects of CPAP on orexin (a hypothalamic neuropeptide which increases food intake) are inconsistent, owing mainly to the small number of studies, which varied in design [6264]. In a within-subject pre–post comparison, treatment with CPAP of 3–4 months was found to reduce plasma orexin when sampled in the morning in the fasted state [63].…”
Section: Resultsmentioning
confidence: 99%
“…However, OSA may also predispose to obesity due to daytime somnolence, decreased activity, and decreased sleep duration, as well as due to neurohumoral changes seen in OSA, including elevation in the orexigenic hormones ghrelin and orexin and suppression of the anorexigenic hormone leptin (seen in many though not all studies of adults with OSA) 343,345347. As discussed in the OSA epidemiology section above, although there is a strong association between OSA and obesity, treatment of OSA in adults may result in weight gain, possibly due to a decrease in resting energy expenditure (which has been found to be proportional to the decrease in AHI and in urinary catechol-amine production and also to CPAP adherence),348 suggesting that decreased sympathetic activation promoted the weight gain with CPAP therapy.…”
Section: Obstructive Sleep Apnea and Cardiometabolic Riskmentioning
confidence: 99%